Archives: Resources
Designing for access: Early integrated evidence generation planning
Learn how early integrated evidence generation planning can align HTA, payer and regulatory needs to support confident access decisions.
Strengthen your precision medicine strategy
Discover how integrated biomarker, laboratory and clinical solutions help accelerate precision medicine programs from strategy to study delivery.
Milestones Ahead! How pre-work eliminates re-work
Discover how integrated biotech development strategy helps reduce rework, close evidence gaps and support faster, higher-value asset progression.
Fully managed services scale testing capacity
Read how fully managed services scaled environmental monitoring testing capacity, reduced cost per test and eased GMP operational burden.
Why “waiting for Phase III” is the most expensive mistake in biotech
Plan early evidence for biotech market access, reimbursement and adoption to reduce Phase III evidence gaps and support long-term value.
Unlocking the power of primary care in chronic disease research
Explore the critical role primary care physicians play in chronic disease management and the value they bring to clinical research.
The 2026 FSP Trends Report
Explore 2026 FSP trends to see how sponsors manage trial complexity, access talent and guide outsourcing decisions.
Metabolic advancing platform
Learn how our metabolic advancing platform can help simplify and strengthen your obesity and metabolic programs.
The Biotech Pulse Report 2026
Explore the 2026 Biotech Pulse survey report to help biotech leaders strengthen clinical development decisions, protect momentum and meet key milestones.